Cargando…
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
Stem cell characteristics have been associated with treatment resistance and poor prognosis across many cancer types. The ability to induce and regulate the pathways that sustain these characteristic hallmarks of lethal cancers in a novel in vitro model would greatly enhance our understanding of can...
Autores principales: | Hepburn, A. C., Steele, R. E., Veeratterapillay, R., Wilson, L., Kounatidou, E. E., Barnard, A., Berry, P., Cassidy, J. R., Moad, M., El-Sherif, A., Gaughan, L., Mills, I. G., Robson, C. N., Heer, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546609/ https://www.ncbi.nlm.nih.gov/pubmed/30742096 http://dx.doi.org/10.1038/s41388-019-0712-y |
Ejemplares similares
-
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
por: Hepburn, A. C., et al.
Publicado: (2019) -
Propagation of human prostate tissue from induced pluripotent stem cells
por: Hepburn, Anastasia C., et al.
Publicado: (2020) -
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities
por: Kounatidou, Evangelia, et al.
Publicado: (2019) -
Side Population in Human Non-Muscle Invasive Bladder Cancer Enriches for Cancer Stem Cells That Are Maintained by MAPK Signalling
por: Hepburn, Anastasia C., et al.
Publicado: (2012) -
Identification of CNGB1 as a Predictor of Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Hepburn, Anastasia C., et al.
Publicado: (2021)